Clinical trial
Comparison of Aprepitant vs. Gabapentin in the Prevention of Delayed Nausea and Vomiting
NCT00250744 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Aprepitant vs. Gabapentin in the Prevention of Delayed Nausea and Vomiting
- Lead sponsor
- New Mexico Cancer Research Alliance
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2004
- Completion date
- September 30, 2007
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer